NTLA

Intellia Therapeutics, Inc. Common Stock

$19.89 +$0.17 +0.85%



Shares Bought14
Shares Sold14
Total28
Shares Owned0
Last Price$19.89
Total Return$26.40
Range Today$19.39 - $20.02
52 Week Range$10.83 - $33.34
Open$19.84
Market Cap$718.10M
Volume/Average198.14K/319.29K
P/E Ratio-
Dividend/Yield-




Intellia Therapeutics, Inc. engages in the development of proprietary, potentially curative therapeutics. It provides scientific expertise, clinical development and intellectual property position to unlock broad therapeutic applications of CRISPR or Cas9 genome editing and develop a potential new drug class. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
10-09-17 18:11 10-16-17 19:11 $28.84 $26.75 -$2.09 -7.24% crizisaround genovahero
10-09-17 20:30 10-16-17 19:08 $29.30 $26.73 -$2.57 -8.77% genovahero
09-26-17 19:43 10-03-17 20:31 $23.44 $30.55 +$7.11 +30.33% crizisaround manthello
09-26-17 19:41 10-03-17 20:25 $23.45 $30.55 +$7.10 +30.28% manthello
09-26-17 19:40 09-29-17 21:59 $23.47 $24.60 +$1.13 +4.81% manthello
09-08-17 15:20 09-22-17 15:31 $21.71 $24.96 +$3.25 +14.97% grifftenstein
09-08-17 15:18 09-22-17 15:29 $21.71 $25.00 +$3.29 +15.16% grifftenstein
09-08-17 15:21 09-22-17 15:28 $21.70 $25.00 +$3.30 +15.22% crizisaround grifftenstein
08-14-17 13:04 08-24-17 16:41 $16.93 $17.11 +$0.18 +1.06% edwardst
08-04-17 17:19 08-24-17 16:39 $16.10 $17.13 +$1.03 +6.40%
08-04-17 17:17 08-24-17 16:16 $16.14 $17.14 +$1.00 +6.20%
08-04-17 17:16 08-23-17 20:00 $16.13 $17.26 +$1.13 +7.01%
08-04-17 17:20 08-23-17 19:58 $16.10 $17.42 +$1.32 +8.20% manthello
08-04-17 17:15 08-22-17 15:35 $16.09 $17.30 +$1.21 +7.53%